A phase Ib study of selumetinib in patients (pts) with previously untreated metastatic Non-Small Cell Lung Cancer (NSCLC) receiving standard chemotherapy: NCIC Clinical Trials Group IND.215. NCT01783197. Conferences uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Nicholas, Garth Andrew
  • Goffin, John
  • Laurie, Scott Andrew
  • Robinson, Andrew George
  • Goss, Glenwood D
  • Reaume, M Neil
  • Mates, Mihaela
  • Wheatley-Price, Paul
  • Ellis, Peter
  • Juergens, Rosalyn
  • Tomiak, Anna T
  • Gregg, Richard William
  • Melosky, Barbara L
  • Tu, Dongsheng
  • Ritter, Heather
  • Seymour, Lesley
  • Bradbury, Penelope Ann

publication date

  • May 20, 2015